stockrowThermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.
- Revenue
- +9.13%
- EPS
- +8.64%
- Free cash flow
- +15.0%
- Total debt
- +22.8%
Quarter to September 2026, against a year earlier
Follow TMO
Alert me
Thermo Fisher Scientific Inc. (TMO) Revenue growth
Thermo Fisher Scientific Inc.'s revenue growth over the twelve months to 30 September 2026 was 8.27%, up 4.4 percentage points from fiscal 2025 (3.91%). Over the past ten years it has ranged from −4.58% (fiscal 2023) to 26.1% (fiscal 2020); the current reading is higher than 36% of that period. That is below the Diagnostics & Research industry median of 8.99% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 3.91% | 3.86 |
| FY2024 | 0.05% | 4.63 |
| FY2023 | −4.58% | (19.13) |
| FY2022 | 14.6% | (7.16) |
| FY2021 | 21.7% | (4.43) |
| FY2020 | 26.1% | 21.28 |
| FY2019 | 4.86% | (11.59) |
| FY2018 | 16.5% | 1.98 |
| FY2017 | 14.5% | 6.75 |
| FY2016 | 7.72% | 7.27 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 9.13% | (1.36) |
| Jun 2026 | 10.5% | 4.31 |
| Mar 2026 | 6.18% | (1.02) |
| Dec 2025 | 7.20% | 2.26 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 80.7% |
| NTRA Natera, Inc. compare | 37.4% |
| IDXX IDEXX Laboratories, Inc. compare | 11.9% |
| IQV IQVIA Holdings Inc. compare | 8.85% |
| A Agilent Technologies, Inc. compare | 8.60% |
| TMO Thermo Fisher Scientific Inc. | 8.27% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| ILMN Illumina, Inc. compare | 5.83% |
| DHR Danaher Corporation compare | 5.52% |
| Diagnostics & Research industry median | 8.99% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement